MichaelLucasVolkMD
Gastroenterology • Temple, TXHepatology & Liver Transplantation
Chair of Medicine, Baylor Scott and White
Dr. Volk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 S 31st St
Temple, TX 76508Phone+1 254-724-2111
Summary
- Michael L Volk, MD, MSc, FAASLD, is Chair of Medicine at Baylor Scott and White, Central Texas Region. Previously he was Chief of Gastroenterology/Hepatology and Medical Director of Liver Transplantation at Loma Linda University Health in California. He received his medical degree from the University of Rochester School of Medicine, and completed his internal medicine residency at the University of Virginia Hospital in Charlottesville and fellowship in gastroenterology and hepatology at the University of Michigan Hospital in Ann Arbor. Dr Volk specializes in improving medical decision-making and healthcare delivery for patients with chronic liver disease. As a researcher, he has published more than 150 papers and received multiple research grants, and as a clinician, he was frequently voted one of the Best Doctors in Hepatology.
Education & Training
University of MichiganFellowship, Gastroenterology, 2004 - 2007
University of Virginia Medical CenterResidency, Internal Medicine, 2001 - 2004
University of Rochester School of Medicine and DentistryClass of 2001
Certifications & Licensure
TX State Medical License 2023 - 2025
CA State Medical License 2014 - 2024
NV State Medical License 2015 - 2023
MI State Medical License 2006 - 2016
VA State Medical License 2001 - 2004- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Hepatitis C Virus (HCV) Positive Liver Grafts in HCV Negative Recipients Start of enrollment: 2018 Sep 02
Publications & Presentations
PubMed
- 12 citationsDisease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention.Lisa M. Glass, Haila Asefa, Michael L. Volk, Anna S. Lok, Monica A. Tincopa
Digestive Diseases and Sciences. 2021-05-27 - 466 citationsThe Epidemiology of Cirrhosis in the United States: A Population-based Study.Steven Scaglione, Stephanie Kliethermes, Guichan Cao, David A. Shoham, Ramon Durazo
Journal of Clinical Gastroenterology. 2015-09-01 - 23 citationsQuality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesSumeet K. Asrani, Marwan Ghabril, Alexander Kuo, Raphael B. Merriman, Timothy R. Morgan
Hepatology. 2021-11-15
Press Mentions
Q&A: Rifaximin plus or Minus Lactulose Reduces ED Visits for Hepatic EncephalopathyNovember 18th, 2021- OmniLife and Loma Linda University Transplant Institute Solidify Research Partnership to Drive InnovationSeptember 14th, 2021
- 1,000 Liver Transplants Have Improved Patients’ and Their Families’ LivesJune 3rd, 2021
- Join now to see all
Grant Support
- Decision Making About Organ Quality In Liver TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2012
Committees
- Member, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD) 2016 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
